Surgery Websites
Transplant Surgery »  Meet the Team »  Emeritus Faculty »  Stephen J. Tomlanovich, M.D.
Stephen J. Tomlanovich, M.D.

Stephen J. Tomlanovich, M.D.

  • Professor Emeritus of Surgery and Medicine
  • Departments of Surgery and Medicine
  • Medical Director, Kidney Transplant Service

Contact Information

Academic Office
(415) 353-8390
Fax: 415.353.8974
[email protected]
Open Popup
  • Notre Dame University, BS 
  • University of Michigan Medical School, MD
  • Rush-Presbyterian-St. Luke's Medical Center, Internal Medicine
  • Henry Ford Hospital, Internal Medicine
  • Stanford University Medical Center, Nephrology
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology - Subspecialty
  • Chronic Kidney Disease
  • End Stage Renal Disease (Kidney Failure)
  • Kidney Transplantation
  • Living Kidney Donor Transplantation
  • Pancreas Transplantation
  • Transplant Nephrology


Dr. Stephen Tomlanovich is a nationally known kidney transplant specialist who has worked to improve patient access to transplants through the development of outreach clinics in communities throughout Northern California.

In addition to caring for patients, he conducts research to help develop new immunosuppressive medications to prevent organ rejection. He is a principal investigator in numerous studies that have led to new immunosuppressive drugs to improve the success rate of transplants while minimizing side effects. He also is involved with regional and national organizations and serves on the board of directors of the California Transplant Donor Network and the Transpacific Renal Network.

Tomlanovich earned a medical degree at the University of Michigan and completed an internship at Rush Presbyterian-St. Luke's Hospital followed by a residency at Henry Ford Hospital in Detroit. In 1985, he completed a nephrology fellowship at Stanford University and joined UCSF Medical Center.

Data provided by UCSF Profiles, powered by CTSI
  1. Qazi Y, Shaffer D, Kaplan B, Kim DY, Luan FL, Peddi VR, Shihab F, Tomlanovich S, Yilmaz S, McCague K, Patel D, Mulgaonkar S. Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data. Am J Transplant. 2017 May; 17(5):1358-1369. View in PubMed
  2. O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB. The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant. 2014 Apr; 14(4):779-87. View in PubMed
  3. Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012 Dec 15; 94(11):1117-23. View in PubMed
  4. Chandran S, Baxter-Lowe L, Olson JL, Tomlanovich SJ, Webber A. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report. Transplant Proc. 2011 Jun; 43(5):2097-101. View in PubMed
  5. Findlay JY, Fix OK, Paugam-Burtz C, Liu L, Sood P, Tomlanovich SJ, Emond J. Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl. 2011 May; 17(5):496-510. View in PubMed
  6. View All Publications


Site Directory